These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 30826661)

  • 21. Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis.
    Callegaro D; Miceli R; Bonvalot S; Ferguson P; Strauss DC; Levy A; Griffin A; Hayes AJ; Stacchiotti S; Pechoux CL; Smith MJ; Fiore M; Dei Tos AP; Smith HG; Mariani L; Wunder JS; Pollock RE; Casali PG; Gronchi A
    Lancet Oncol; 2016 May; 17(5):671-80. PubMed ID: 27068860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors and predictive model in patients with advanced biliary tract adenocarcinoma receiving first-line palliative chemotherapy.
    Park I; Lee JL; Ryu MH; Kim TW; Sook Lee S; Hyun Park D; Soo Lee S; Wan Seo D; Koo Lee S; Kim MH
    Cancer; 2009 Sep; 115(18):4148-55. PubMed ID: 19536892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Second-line therapy in advanced biliary tract cancer: what should be the standard?
    Cereda S; Belli C; Rognone A; Mazza E; Reni M
    Crit Rev Oncol Hematol; 2013 Nov; 88(2):368-74. PubMed ID: 23786845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical insights and prognostic factors from an advanced biliary tract cancer case series: a real-world analysis.
    Filippi R; Leone F; Fornaro L; Aprile G; Casadei-Gardini A; Silvestris N; Palloni A; Satolli MA; Scartozzi M; Russano M; Lutrino SE; Lombardi P; Frega G; Garattini SK; Vivaldi C; Spadi R; Giulia O; Fenocchio E; Brunetti O; Aglietta M; Brandi G
    J Chemother; 2022 Apr; 34(2):123-132. PubMed ID: 34313188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of fluoropyrimidine-based chemotherapy in patients with advanced biliary tract cancer after failure of gemcitabine plus cisplatin: retrospective analysis of 321 patients.
    Kim BJ; Yoo C; Kim KP; Hyung J; Park SJ; Ryoo BY; Chang HM
    Br J Cancer; 2017 Feb; 116(5):561-567. PubMed ID: 28081540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Addition of an antiangiogenic therapy, bevacizumab, to gemcitabine plus oxaliplatin improves survival in advanced biliary tract cancers.
    Bréchon M; Dior M; Dréanic J; Brieau B; Guillaumot MA; Brezault C; Mir O; Goldwasser F; Coriat R
    Invest New Drugs; 2018 Feb; 36(1):156-162. PubMed ID: 28762171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CA19-9 kinetics during systemic chemotherapy in patients with advanced or recurrent biliary tract cancer.
    Takahara N; Nakai Y; Isayama H; Sasaki T; Saito K; Noguchi K; Suzuki T; Nakamura T; Sato T; Ishigaki K; Hakuta R; Takeda T; Uchino R; Mizuno S; Kogure H; Tada M; Koike K
    Cancer Chemother Pharmacol; 2017 Dec; 80(6):1105-1112. PubMed ID: 29038848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic Factors for the Selection of Patients Eligible for Second-Line Chemotherapy in Advanced Biliary Tract Cancer.
    Kang EJ; Choi YJ; Kim JS; Park KH; Oh SC; Seo JH; Kim HJ; Kang KW; Yu ES; Shin SW; Kim YH; Kim JS
    Chemotherapy; 2014; 60(2):91-98. PubMed ID: 25720697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a nomogram to predict survival in advanced biliary tract cancer.
    Imaoka H; Ikeda M; Nomura S; Morizane C; Okusaka T; Ozaka M; Shimizu S; Yamazaki K; Okano N; Sugimori K; Shirakawa H; Mizuno N; Satoi S; Yamaguchi H; Sugimoto R; Gotoh K; Sano K; Asagi A; Nakamura K; Ueno M
    Sci Rep; 2023 Dec; 13(1):21548. PubMed ID: 38057434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic risk stratification derived from individual patient level data for men with advanced penile squamous cell carcinoma receiving first-line systemic therapy.
    Pond GR; Di Lorenzo G; Necchi A; Eigl BJ; Kolinsky MP; Chacko RT; Dorff TB; Harshman LC; Milowsky MI; Lee RJ; Galsky MD; Federico P; Bolger G; DeShazo M; Mehta A; Goyal J; Sonpavde G
    Urol Oncol; 2014 May; 32(4):501-8. PubMed ID: 24332646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model.
    Gravis G; Boher JM; Fizazi K; Joly F; Priou F; Marino P; Latorzeff I; Delva R; Krakowski I; Laguerre B; Walz J; Rolland F; Théodore C; Deplanque G; Ferrero JM; Pouessel D; Mourey L; Beuzeboc P; Zanetta S; Habibian M; Berdah JF; Dauba J; Baciuchka M; Platini C; Linassier C; Labourey JL; Machiels JP; El Kouri C; Ravaud A; Suc E; Eymard JC; Hasbini A; Bousquet G; Soulie M; Oudard S
    Eur Urol; 2015 Aug; 68(2):196-204. PubMed ID: 25277272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of single-day GemOx regimen in patients with pancreatobiliary cancer: a single institution experience.
    Li J; Merl M; Lee MX; Kaley K; Saif MW
    Expert Opin Drug Saf; 2010 Mar; 9(2):207-13. PubMed ID: 20095915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experience of gemcitabine plus oxaliplatin chemotherapy in patients with advanced biliary tract carcinoma.
    Hollebecque A; Bouché O; Romano O; Scaglia E; Cattan S; Zerbib P; Heurgue A; Lagarde S; Mariette C; Triboulet JP; Pruvot FR; Hebbar M
    Chemotherapy; 2010; 56(3):234-8. PubMed ID: 20551640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk estimation for biliary tract cancer: Development and validation of a prognostic score.
    Schweitzer N; Fischer M; Kirstein MM; Berhane S; Kottas M; Sinn M; Gonzalez-Carmona MA; Balta Z; Weismüller TJ; Strassburg CP; Reineke-Plaaß T; Bektas H; Manns MP; Johnson P; Weinmann A; Vogel A
    Liver Int; 2017 Dec; 37(12):1852-1860. PubMed ID: 28695669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of patients with unresectable advanced carcinoma of biliary tract - chemotherapy and surgical resection.
    Morise Z; Sugioka A; Tanahashi Y; Okabe Y; Ikeda M; Kagawa T; Takeura C
    Anticancer Res; 2009 May; 29(5):1783-6. PubMed ID: 19443404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multicentre phase I-II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable pancreatic and biliary tract cancer: The CORGI-U study.
    Gunnlaugsson A; Anderson H; Lind P; Glimelius B; Johnsson A
    Radiother Oncol; 2010 Jun; 95(3):292-7. PubMed ID: 20451275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peritoneal carcinomatosis index predicts survival in colorectal patients undergoing HIPEC using oxaliplatin: a retrospective single-arm cohort study.
    Burnett A; Lecompte MA; Trabulsi N; Dubé P; Gervais MK; Trilling B; Cloutier AS; Sideris L
    World J Surg Oncol; 2019 May; 17(1):83. PubMed ID: 31092250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors in patients treated with second-line chemotherapy for advanced gastric cancer: results from the randomized prospective phase III FFCD-0307 trial.
    Touchefeu Y; Guimbaud R; Louvet C; Dahan L; Samalin E; Barbier E; Le Malicot K; Cohen R; Gornet JM; Aparicio T; Nguyen S; Azzedine A; Etienne PL; Phelip JM; Hammel P; Chapelle N; Sefrioui D; Mineur L; Lepage C; Bouche O
    Gastric Cancer; 2019 May; 22(3):577-586. PubMed ID: 30311042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Factors and Scoring Model for Survival in Metastatic Biliary Tract Cancer.
    Park HS; Park JS; Chun YJ; Roh YH; Moon J; Chon HJ; Choi HJ; Park JS; Lee DK; Lee SJ; Yoon DS; Jeung HC
    Cancer Res Treat; 2017 Oct; 49(4):1127-1139. PubMed ID: 28161931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nomogram for predicting survival in patients with unresectable and/or metastatic urothelial cancer who are treated with cisplatin-based chemotherapy.
    Galsky MD; Moshier E; Krege S; Lin CC; Hahn N; Ecke T; Sonpavde G; Godbold J; Oh WK; Bamias A
    Cancer; 2013 Aug; 119(16):3012-9. PubMed ID: 23720216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.